A study of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) serum levels in rats subjected to fecal peritonitis and treated with intraperitoneal ropivacaine 1 Avaliação dos níveis séricos de interleucina 6 (IL-6) e fator de necrose tumoral (TNF-α) em ratos submetidos a peritonite fecal e tratado com ropivacaína intraperitoneal 
Introduction
The mortality and incidence of sepsis have increased in recent years. In the United States, an annual incidence of 750,000 patients with sepsis is estimated with a mortality rate of 28.6%, which represents a cost of 16.7 billion USD in health care 1 .
Peritonitis is one of the most important causes of sepsis and death in surgery and intensive care units. The anti-inflammatory mechanism of action of local anesthetics is not fully understood but seems to involve a reversible interaction with membrane proteins and lipids, as well as regulation of cellular metabolic activity, migration, phagocytosis and exocytosis. Based on these data, we have investigated the interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα) serum levels in rats subjected to fecal peritonitis by autogenous stool and treated with abdominal cavity lavage containing 0.2% ropivacaine. The sample size determination was based on a previous study, 7 which showed a difference of 40±15 pg/mL in IL-6 levels between the rats that underwent laparoscopy and the rats that underwent laparoscopic ligature following cecum puncture.
Methods
Considering these data, four animals were necessary in each group to obtain a power of 95% and a type I error of 0.05.
The animals were anesthetized by an injection of S(+)
ketamine hydrochloride (Cristalia®, São Paulo, Brazil) in the anterior muscle of the right thigh at a dose of 10 mg/kg of body weight. 8 Rats were also subjected to an abdominal puncture with a 16G Teflon catheter in the left lower quadrant of the abdomen.
Next, an autogenous suspension of newly defecated feces was injected into the abdominal cavity, which was prepared with 2 g of feces diluted in 17 mL of saline. Before injection, the suspension was filtered through gauze to allow its free passage through the interior of the needle. From this suspension, 10 mL/kg of body weight was injected in the abdominal cavity. The animals were divided into the following groups:
Group I-(n = 4) control, no treatment; Group II-(n = 4) smooth drying of the contents in the abdominal cavity with dry gauze; Group III-(n = 4) lavage of the abdominal cavity with 3 mL of 0.9% saline followed by drying and Group IV-(n = 4) lavage of the abdominal cavity with 3 mL of 0.2% ropivacaine and drying.
In groups III and IV, after drying of the abdominal cavity with dry gauze, saline (group III) or 0.2% ropivacaine (group IV) was injected and maintained in the cavity for three minutes. During this period, the solution was carefully distributed among the abdominal viscera to allow greater contact with the peritoneum.
After this procedure, the peritoneal fluid was wiped gently with dry gauze to remove as much liquid as possible. The abdominal wall was sutured in a single plane with a simple running suture using mono nylon (4-0).
Six hours after surgery, blood samples were collected (1 mL) from each animal in all groups by cardiac puncture with a 25G x 5.5 needle to assess the levels of IL-6 and TNF-α. After blood collection, all animals were euthanized intraperitoneally with pentobarbital (Cristalia®, São Paulo, Brazil) at a dose of 50 mg/kg of body weight. Cytokine assessment was performed using the CBA (Cytometric Bead Array) method according to previously described methodology. 9 To compare the measurements of IL-6 and TNF-α, we applied the non-parametric Mann-Whitney test because the normality hypothesis was rejected. A p-value <0.05 was considered to be statistically significant. Statistical analysis was performed using the SPSS 19.0 software.
Results

TABLE 1
shows that the concentrations of TNF-α were lower (P <0.05) in the ropivacaine group compared with those of other groups. 
Discussion
Previous studies have shown reduced mortality in rats subjected to fecal peritonitis that underwent lavage of the peritoneum with lidocaine 10 and bupivacaine. 11 Ropivacaine, despite having milder anti-inflammatory and anti-microbial activities compared with other anesthetics, 12 blunted the increase in plasma levels of TNF-α compared with other groups in our study. Conversely, although the levels of IL-6 were lower in the ropivacaine group compared with the other groups, this difference was not statistically significant compared to the control group that received saline. These results corroborate reported data suggesting the efficacy of using local anesthetics to reduce inflammation in experimental models of septic peritonitis.
Local anesthetics appear to act at various stages of the inflammatory cascade. Several studies have shown a reversible and dose-dependent reduction in leukocyte adhesion to the vascular wall following anesthetic treatment. 13, 14 Leukocyte migration also appears to be affected by local anesthetics, probably due to actions on the cytoskeleton or decreases in the release of chemotactic agents by leukocytes. 15 Local anesthetics also produce a dose-dependent and reversible inhibition of granulocyte phagocytosis. A previous study has shown that intravenous administration of lidocaine at doses recommended for anti-arrhythmic treatment significantly reduced the phagocytic activity of leukocytes in the synovial fluid of joints with synovitis. 16 Experiments with ropivacaine, however, showed modest effects on the granulocytes phagocytic activity, in contrast to the results obtained with other local anesthetics. 12 The most plausible mechanism to explain the inhibition of phagocytic activity is a decrease in the surface receptor expression of leukocytes 17 and inhibition of actomyosin filament activity.
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Although the efficacy of peritoneal lavage is controversial in the medical literature, 19, 20 a previous study conducted by the same author showed a significant reduction in mortality when local anesthetics were used in the peritoneum. 10 Local anesthetics increased survival in several studies using experimental models with mice 21 and dogs 22 , even when administered systemically.
Besides their immunomodulatory effects, local anesthetics have proven antimicrobial activity. Other studies have shown that the antimicrobial potency of local anesthetics is primarily related to concentration and, to a lesser extent, chemical structure. Thus, anesthetics may be effective against most bacteria at sufficiently high concentrations. 23 The precise mechanism of antibacterial activity is still unclear but may be related to the interaction of local anesthetics with the bacterial cell wall or cell surface macromolecules.
Electrostatic interactions between cationic local anesthetics and anionic membrane components could induce functional changes in the cell membrane therefore reducing the membrane fluidity. 24 In this study, peritoneal lavage with saline was not effective for decreasing IL-6 and TNF-α levels compared with the control and drying groups. Although not statistically significant, the of IL-6 measurements had lower p-values than those found for TNF-α. This finding is probably due to the half-life of the studied cytokines and the time of sample collection.
Other studies have shown that TNF-α has a peak plasma concentration of 2 hours followed by a rapid decline (18.2 min.
half-life), and IL-6 has a biphasic peak concentration at 6 and 74 hours after exposure to endotoxin. 25 . Because the collection was performed 12 hours after the induction of peritonitis, TNF-α concentrations were probably decreasing, which caused the treatment groups to exhibit similar results.
The lack of statistically significant differences in the IL-6 results determined for the ropivacaine and saline groups was due to the confidence-interval values for the ropivacaine group, which were included in the saline-group interval.
Conclusion
Peritoneal lavage with 0.2% ropivacaine in the treatment of fecal peritonitis induced with autogenous stool in rats reduced the plasma levels of IL-6 and TNF-α-related to the inflammatory response and sepsis.
